Abstract
According to Italian data, people who inject drugs (PWID) have high prevalence of Hepatitis C Virus (HCV) infection (30-60%). PWID have inadequate access to directly acting antivirals (DAA) due to (1) their mistrust towards the healthcare system and (2) the lack of coordination between medical specialists who play a pivotal role in the diagnosis and treatment of HCV infection. We aim to describe the HCV -treatment cascade of care in Trieste on PWID.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
